The prevalence of papillary thyroid cancer (PTC), particularly of low-risk PTC (MACIS< 6), is
rising due to the increasingly use of neck imaging techniques, fine-needle aspiration and …

The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-
risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to …

We are witnessing a rapid worldwide increase in the incidence of papillary thyroid
carcinoma (PTC) in the last thirty years. Extensive implementation of cancer screening and …

Low-risk papillary cancers, which represent the vast majority of thyroid cancers diagnosed
today, do not require aggressive treatment or follow-up. Initial treatment consists of a total …

Opinion statement The incidence of epithelial derived thyroid cancer (papillary thyroid
cancer [PTC] and follicular thyroid cancer, known collectively as differentiated thyroid …

Increasingly sensitive diagnostic methods, better understanding of molecular
pathophysiology, and well-conducted prospective studies have changed the current …

Papillary thyroid carcinoma (PTC) accounts for over 90% of all thyroid cancers in Japan. The
majority of patients with PTC are categorized into a low-risk group according to the recent …

An ever-increasing population of patients with papillary thyroid cancer is engaging with
health care systems around the world. Numerous questions about optimal management …

Low-risk papillary thyroid carcinoma (PTC) has been treated using lobectomy in Japan. This
represents a very different approach to that used in Western countries, where the majority of …

After the update of the American Thyroid Association (ATA) guidelines on diagnosis and
treatment of patients with thyroid cancer in 2015 [1], it became evident that, for patients with …